Quantcast
FDA Approves Contrave A New Drug To Battle Obesity

FDA Approves Contrave, A New Drug To Battle Obesity

John Hopton for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise. It...

Latest Naltrexone Stories

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-18 12:27:20

ORLANDO, Fla., Aug. 18, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is providing a second notice of TNI BioTech's annual meeting of September 4, 2014. In making the announcement, Noreen Griffin, founder and CEO of TNI BioTech Inc. said, "Thank you in advance for your participation in...

2014-07-24 08:34:19

BALTIMORE, July 24, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB - BICX). The healthcare solutions company is on the leading edge of substance abuse addiction treatment. BioCorRx developed the highly effective Start Fresh Program(TM) which is sold to and used by addiction clinics across the U.S. The alcohol and...

2014-06-24 08:30:45

ORLANDO, Fla., June 24, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") a biotechnology company pioneering the development of innovative therapies for autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system, announced today that its Board of Directors had passed a resolution cancelling the previously announced 9:10 reverse split of its common stock, as per the 14A Information Statement filed...

2014-06-20 23:03:17

Las Vegas Rapid Detox Medical Clinic is pleased to announce that they reached the milestone of performing 500 successful rapid opiate detox procedures without any complications. Las Vegas, NV (PRWEB) June 20, 2014 Opiate detox can be an extremely painful thing to go thorugh. However, with Las Vegas Rapid Detox’s groundbreaking 8 hour rapid detox procedure, patients can detox from opiates in only eight hours without suffering any signs of withdrawal. Las Vegas Rapid Detox’s procedure...

2014-06-01 23:02:18

Aid in Recovery released a statement today supporting a recent commentary co-authored by various federal health agencies calling for increased funding and expanded health coverage for drug addiction medication treatments. With proper prescription and monitoring, health officials argue that medication treatments can help cut costs and save lives. Stuart, Florida (PRWEB) June 01, 2014 Aid in Recovery, a full service drug and alcohol treatment center servicing south Florida, released a...

2014-05-29 23:19:59

The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US. The conference reviews, compares and contrasts the most recent data and treatments for a variety of Auto-Immune and Immuno-modulated Conditions. (PRWEB) May 29, 2014 International conference to raise awareness about a ground-breaking drug. Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and...

Treating Alcohol, Opioid Dependence With Extended-release Medication
2014-05-15 03:12:27

Oregon State University A comparatively new form of a medication for alcohol and opioid dependence that’s injected once a month instead of taken orally once a day appears to be significantly more effective than some other medications – because more patients actually continue the prescribed regimen. The findings, published in the Journal of Substance Abuse Treatment by researchers from Oregon State University and other institutions, offer support for a wider use of medications that...

Researchers Combine Graphene And Painkiller Receptor
2014-05-13 03:09:16

University of Pennsylvania Almost every biological process involves sensing the presence of a certain chemical. Finely tuned over millions of years of evolution, the body’s different receptors are shaped to accept certain target chemicals. When they bind, the receptors tell their host cells to produce nerve impulses, regulate metabolism, defend the body against invaders or myriad other actions depending on the cell, receptor and chemical type. Now, researchers from the University of...

2014-04-16 16:30:50

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q7jzmk/sustained_release) has announced the addition of the "Concise Analysis of International Sustained Release Injectables to 2020" [http://www.researchandmarkets.com/research/q7jzmk/sustained_release ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Formulations, Dosing, Devices, Markets and Forecasts The ability...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.